Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Vaccine”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT05254561
What this trial is testing

Triple Antigen vs Monoantigen Immunotherapy for Warts

Who this might be right for
Triple Intralesional Immunotherapy Combination in Multiple Recalcitrant Warts
Zagazig University 160
Large-scale testing (Phase 3)WithdrawnNCT02082639
What this trial is testing

Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus Vaccine (Cervarix™) When Co-administered With GSK Biologicals' Hepatitis A Vaccine (Havrix®) in Healthy Female Adolescents Aged 9-14 Years

Who this might be right for
Infections, Papillomavirus
GlaxoSmithKline
Early research (Phase 1)Study completedNCT02947854
What this trial is testing

Study to Assess Safety, Tolerability and Immune Response of Fimaporfin-induced Photochemical Internalisation of Antigen/Adjuvant

Who this might be right for
Healthy Volunteer
PCI Biotech AS 96
Testing effectiveness (Phase 2)Ended earlyNCT01545141
What this trial is testing

Chemokine-Modulatory Regimen for Recurrent Resectable Colorectal Cancer

Who this might be right for
Colorectal CancerColorectal CarcinomaColorectal Tumors+1 more
Roswell Park Cancer Institute 15
Testing effectiveness (Phase 2)Study completedNCT00101101
What this trial is testing

Universal Granulocyte Macrophage-colony Stimulating Factor (GM-CSF)-Producing and GM.CD40L for Autologous Tumor Vaccine in Mantle Cell Lymphoma

Who this might be right for
Lymphoma
H. Lee Moffitt Cancer Center and Research Institute 43
Early research (Phase 1)Study completedNCT00868595
What this trial is testing

MTD Study of Vaccine BP-GMAX-CD1 Plus AP1903 to Treat Castrate Resistant Prostate Cancer

Who this might be right for
Castrate Resistant Prostate Cancer (CRPC)
Bellicum Pharmaceuticals 18
Testing effectiveness (Phase 2)Study completedNCT02649439
What this trial is testing

Prostvac in Patients With Biochemically Recurrent Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 97
Large-scale testing (Phase 3)Study completedNCT00877877
What this trial is testing

Evaluation of Long-term Immunogenicity and Safety of a Human Papillomavirus (HPV) Vaccine in Healthy Female Subjects.

Who this might be right for
Infections, PapillomavirusPapillomavirus Vaccines
GlaxoSmithKline 632
Testing effectiveness (Phase 2)Active Not RecruitingNCT03096093
What this trial is testing

Investigation of a Therapeutic Vaccine (ACIT-1) in Cancer

Who this might be right for
CancerNeoplasms
Cancer Vaccines Limited 34
Not applicableUnknownNCT00863187
What this trial is testing

Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab

Who this might be right for
Lymphoma
Rambam Health Care Campus 100
Large-scale testing (Phase 3)Study completedNCT00092534
What this trial is testing

Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil) (V501-015)

Who this might be right for
Cervical CancerGenital Warts
Merck Sharp & Dohme LLC 12,167
Testing effectiveness (Phase 2)Study completedNCT00849121
What this trial is testing

Two-Arm Study of a DNA Vaccine Encoding Prostatic Acid Phosphatase (PAP) in Patients With Non-Metastatic Castrate-Resistant Prostate Cancer

Who this might be right for
Prostate Cancer
University of Wisconsin, Madison 17
Early research (Phase 1)UnknownNCT04864379
What this trial is testing

Clinical Study of a Personalized Neoantigen Cancer Vaccine Combined With Anti-PD-1 and RFA in Patients With Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumor
Sir Run Run Shaw Hospital 30
Not applicableEnrolling By InvitationNCT06144229
What this trial is testing

Real-world Effectiveness of HPV Vaccine in Women Living With HIV and Its Impact on Cervical Cancer Screening Accuracies

Who this might be right for
HivHpv
University of California, Los Angeles 650
Not applicableUnknownNCT05949775
What this trial is testing

Clinical Study of mRNA Vaccine in Patients With Advanced Malignant Solid Tumors

Who this might be right for
Advanced Malignant Solid Tumors
Stemirna Therapeutics 20
Testing effectiveness (Phase 2)Ended earlyNCT03563157
What this trial is testing

QUILT 3.071: NANT Colorectal Cancer (CRC) Vaccine

Who this might be right for
Colorectal Cancer MetastaticmCRC
ImmunityBio, Inc. 2
Testing effectiveness (Phase 2)UnknownNCT05986981
What this trial is testing

MUC1 Therapeutic Tumor Vaccine in Advanced Solid Cancers

Who this might be right for
Solid Tumor, Adult
Peking Union Medical College Hospital 20
Testing effectiveness (Phase 2)Study completedNCT00952692
What this trial is testing

Study to Assess dHER2+AS15 Cancer Vaccine Given in Combination With Lapatinib to Patients With Metastatic Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Michael Morse, MD 12
Early research (Phase 1)Study completedNCT01526473
What this trial is testing

A Phase I Study To Evaluate The Antitumor Activity And Safety Of AVX901

Who this might be right for
HER2+ Cancer
H. Kim Lyerly 22
Testing effectiveness (Phase 2)Looking for participantsNCT06675201
What this trial is testing

Neoantigen Vaccines in Esophageal Squamous Cell Carcinoma

Who this might be right for
Esophageal Squamous Cell Carcinoma (ESCC)Neoantigen-loaded Dendritic Cell VaccineImmune Checkpoint Inhibitors (ICIs)
Sichuan University 165
Next Page